The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 9.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (13 analysts) rates it buy, with a mean price target of $62.
McCormick & Company
MKC · a US exchange · USD · Market cap $14.9B · 14,100 employees
McCormick & Company, Incorporated manufactures, markets, and distributes herbs, spices, seasoning mixes, condiments, and other flavorful products to the food industry.
PASS · Titan Ethical · score 84.4At the last full screen
2026-08-21
Screened 2026-08-21 · the tape above runs as of 16:37 UTC · 29 Aug · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
McCormick & Company holds its Markup at $55.41. Elevated stress, defensive posture warranted, held for 1 days.
| Phase | Markup |
| Quantitative state | Elevated stress, defensive posture warranted, held for 1 days |
| Price at the screen | $55.41 |
| Valuation | 9.22 trailing · 16.80 forward price to earnings |
| Values screen | PASS · score 84.4 |
| Beta | 0.63 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 31.54% | Below 33% | Interest-bearing debt is just 31.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 2.28% | Below 33% | Cash held in interest-bearing accounts and securities is 2.3% of assets, under the one-third limit. | Pass |
| Receivables | 5.49% | Below 49% | Money owed to the company is 5.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.59% | Below 5% | Only 0.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 13% discount to our $62.47 fair value, strong competitive moat, 16.70% revenue growth.
Fair value range in USD, drawn from the 2026-08-21 screen. The gold marker is the market price at the same screen. A 12.7% margin of safety to the base estimate.
Third-party analyst targets: 13 covering, consensus Buy. The average target sits +8% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSpice rack staple with real staying power
Think about the last time you reached for oregano or a taco seasoning packet. McCormick sits behind most of those everyday choices, selling herbs, spices and mixes through supermarkets and food makers alike. The business clears a strong moat, passes the ethical screen and trades at a forward multiple of 15.6 times with 21 percent headroom to fair value.
Revenue is running 17 percent higher, profit margins sit at 22 percent and return on equity reaches 25 percent. Thirteen analysts carry a buy consensus with a median target near 60 dollars, which lines up with the numbers rather than fighting them. Defensive consumer staples rarely combine that kind of profitability with a sensible price.
Raw material swings and private-label pressure can still squeeze margins when harvests disappoint or shoppers trade down. Growth may also slow once post-pandemic stocking normalises. Analysis, not advice.
| Forward P/E | 16.8xfairly priced for its growth rate |
| Trailing P/E | 9.2xvery cheap relative to earnings |
| EPS, trailing | 6.01 |
| EPS, forward | 3.30 |
| Revenue growth | +16.7%steady growth |
| Profit margin | 21.9%healthy profit margins |
| Return on equity | 24.7%an exceptional return on shareholder capital |
| FCF yield | 4.79% |
| Dividend yield | 4.13% |
| Debt to equity | 0.65moderate, manageable leverage |
| Current ratio | 0.78below 1: short-term bills exceed liquid assets |
| Beta | 0.63steadier than the market |
| 52-week range | 44.82 - 72.58 |
| Moat | STRONG |
| Market cap | $14.9B |
| Employees | 14,100 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMKC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 33%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (13 analysts) rates it buy, with a mean price target of $62.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-10 | HATTERSLEY GAVIN D K | Director | 2,000 | $105,960 | |
| 2025-10-08 | KURZIUS LAWRENCE ERIK | Beneficial Owner of more than 10% of a Class of Security | 50,000 | $2,498,000 | |
| 2025-10-08 | KURZIUS LAWRENCE ERIK | Beneficial Owner of more than 10% of a Class of Security | 50,000 | $3,293,000 | |
| 2025-03-14 | RODKIN GARY M | Director | 1,344 | · | |
| 2025-03-14 | THOMAS TERRY S. | Director | 1,344 | · | |
| 2025-03-14 | REPAS GREGORY | Officer | 711 | · | |
| 2025-03-14 | JENKINS KATHERINE | Officer | 319 | · | |
| 2025-02-13 | PRESTON MARGARET M V | Director | 7,150 | $550,764 | |
| 2025-01-27 | REPAS GREGORY | Officer | 1,626 | · | |
| 2025-01-27 | SANCHEZ ANA | Officer | 2,259 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 27 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 23 Sept2025 | Julie Johnson | Democrat | buy | 1K–15K |
| 23 Sept2025 | Julie Johnson | Democrat | sell | 1K–15K |
| 23 Sept2025 | Julie Johnson | Democrat | buy | 1K–15K |
| 23 Sept2025 | Julie Johnson | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $47.07 | +5.0% | · | $1,050 | +5.0% |
| 2 months | $53.24 | -7.1% | $0.48 | $938 | -6.2% |
| 3 months | $56.81 | -13.0% | $0.48 | $879 | -12.1% |
| 6 months | $64.90 | -23.8% | $0.96 | $777 | -22.3% |
| 1 year | $73.44 | -32.7% | $1.86 | $699 | -30.1% |
| 2 years | $64.68 | -23.6% | $3.60 | $820 | -18.0% |
| 3 years | $84.21 | -41.3% | $5.22 | $649 | -35.1% |
| 5 years | $79.72 | -38.0% | $8.16 | $723 | -27.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MKC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.